|
Market Closed -
Swiss Exchange
11:40:59 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 9.828 CHF | +1.23% |
|
-0.22% | +52.09% |
| Current month | -6.68% | ||
| 1 month | +7.57% |
Main features
| IE00BM8R0N95 | Fees | 0.5% | Dividend Policy | Market Cap | |
|---|---|---|---|---|---|
| Currency | CHF | AuM (CAD) | 92.46M | Replication Method | Direct (Physical) |
| Number of securities | 49 | AuM evolution | - | Date of creation | 2021-11-03 |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | Developed markets |
| Theme and Sector | BioTech & Genomics |
The Funds investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index (the Index).
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-14 | CHF 9.828 | +1.23% | 0 |
| 26-10-13 | CHF 9.709 | -2.81% | 0 |
| 26-10-12 | CHF 9.990 | +1.74% | 2,789 |
| 26-10-09 | CHF 9.819 | +1.78% | 5,956 |
| 26-10-08 | CHF 9.647 | -2.06% | 236 |
- Stock Market
- ETF
- GNOM ETF
Select your edition
All financial news and data tailored to specific country editions




















